OBJECTIVES: Total anomalous pulmonary venous connection (TAPVC) occurs as isolated cases, in combination with single ventricle physiology, and may be complicated by pulmonary venous obstruction. We sought to identify potential risk factors for long-term mortality and reoperations.
INTRODUCTION
Total anomalous pulmonary venous connection (TAPVC) is a rare malformation. It occurs in only 1-3% of all cardiac anomalies [1] . Surgical mortality has declined from over 30% in the 1970s [2] to 0-10% in the last decade [3, 4] . Advances in diagnosis, intensive care medicine and surgical technique have led to improved survival [5] [6] [7] [8] . However, unfavourable anatomical characteristics, such as preoperative pulmonary venous obstruction and single ventricle physiology, still remain important determinants of survival [3, 4, 6, 9] . Furthermore, outcome may be related to the type of the anomalous connection. There is evidence that the infracardiac and cardiac types of TAPVC are associated with poor survival [6] . In addition, the surgical technique and the bypass strategy may influence mortality and freedom from reoperation after repair. The so-called 'sutureless technique' might avoid recurrent pulmonary venous stenosis [10, 11] . With regard to the bypass strategy, Karamlou et al. [6] and Mueller et al. [3] achieved excellent results with low-flow cardiopulmonary bypass instead of deep hypothermic circulatory arrest. Also, Hawkins et al. demonstrated improved results using absorbable sutures for connecting the pulmonary venous confluence to the left atrium [8] .
In the present study, we first sought to evaluate the results of 193 patients after TAPVC repair in terms of survival, freedom from cardiac reoperation and freedom from reoperation for pulmonary venous obstruction. Our second aim was to analyse the potential influence of anatomical and clinical factors on outcomes and to evaluate whether differences in bypass strategy or suture material had any influence on overall mortality or reoperation.
PATIENTS AND METHODS

Study population
The data of 193 consecutive patients who had undergone repair of TAPVC between 1974 and 2011 were included. At the time of operation, 102 patients (52.8%) were younger than 1 month. The TAPVC was supracardiac, cardiac, infracardiac and mixed in 45.0, 18.0, 31.2 and 5.8% of the patients, respectively. A functional single ventricle and pulmonary venous obstruction were present in 5.9 and 50.3% of the patients, respectively (Table 1) . Of the total, 177 patients (91.7%) presented with isolated TAPVC. The remaining 16 patients (8.3%) presented with additional cardiac malformations and were defined as complex TAPVC (Table 2) .
Operative data
Before 1990, a transverse incision in the right atrium was performed. This incision was extended from the right side of the heart across the septum into the left atrium to the base of the left atrial appendage. Finally, a longitudinal incision in the horizontal pulmonary venous confluence was used to connect the pulmonary venous confluence to the left atrium. After 1990, the heart was tilted to the right side to expose the left atrium and the pulmonary venous confluence. Then, the left atrium was opened from the left atrial appendage anterior to the pulmonary venous confluence. Finally, a longitudinal incision in the horizontal pulmonary venous confluence was used to connect the pulmonary venous confluence to the left atrium.
In most patients (n = 146, 75.6%), myocardial protection was performed with deep hypothermia (18°C), and the operation was performed in deep hypothermic circulatory arrest. Cold cristalloid cardioplegia was administered during the last decade, and the operation was performed using low-flow cardiopulmonary bypass and moderate hypothermia (28°C). In the earlier period, a non-absorbable suture was used (n = 40); since 1983, absorbable sutures have been used exclusively. The change in the operative strategy reflects a change in our institutional policy. There are no anatomical or clinical factors or preferences of different surgeons that had an influence on the surgical approach.
The diagnosis of pulmonary venous obstruction was obtained from the preoperative notes, including echocardiographic and angiographic examinations. In addition, pulmonary venous obstruction was defined as present in all patients with infracardiac connection. Finally, the diagnosis was confirmed intraoperatively.
Follow-up
Final follow-up was conducted between 2009 and 2012. For the end-points death and reoperation, follow-up is complete for 183 patients (94.8%). Ten patients were lost to final follow-up at a mean time of 8.7 ± 9.5 years.
Statistical analysis
Frequencies are given as absolute numbers and percentages. Continuous data are expressed in terms of the mean and standard deviation or median with ranges. The probability of freedom from events was estimated according to the Kaplan-Meier method. The time of the TAPVC repair was designated as time zero. Freedom-from-event curves were compared using the log-rank test. Hazard rates were estimated according to the Cox proportional model. The following potential risk factors for the end-points mortality, cardiac reoperation and reoperation for pulmonary venous obstruction were entered in the univariate analyses: gender male; age <30 days at TAPVC repair; surgical era <1990; supracardiac TAPVC; cardiac TAPVC; infracardiac TAPVC; mixed TAPVC; pulmonary venous obstruction; complex heart defect; single ventricle; right isomerism; hypothermic circulatory arrest; pulmonary hypertension; and non-absorbable suture. Multivariate analyses were performed by means of a Cox proportional hazard model. Variables with P values <0.5 in univariate analysis were entered into the multivariate models. For the subgroup analyses of patients presenting with isolated TAPVC, the 16 patients with complex cardiac malformation were excluded. Analyses were performed with SPSS 20.0 for Windows (SPSS Inc., Chicago, IL, USA).
Institutional Review Board approval was obtained to conduct this retrospective follow-up study. The authors had full access to the data and take full responsibility for the integrity of the data.
RESULTS
Total study population of 193 patients
Survival. During the follow-up period, 31 patients died. Survival was 82.7 ± 2.9% at 20 years (Fig. 1A) . Among the potential risk factors listed in Table 1 , pulmonary venous obstruction (P = 0.044), complex heart defect (P < 0.001), single ventricle physiology (P < 0.001) and right isomerism (P < 0.001) were significantly associated with overall mortality. Single ventricle physiology (P < 0.001) emerged as the only significant risk factor for mortality in the multivariate model (Table 3 , Fig. 1B ).
Cardiac reoperations. Thirty cardiac reoperations were performed in 27 patients. Freedom from any cardiac reoperation, including reoperations for pulmonary venous obstruction, was 82.2 ± 3.3% at 20 years (Fig. 1C) . Among the potential risk factors listed in Table 1 , surgical era <1990 (P = 0.018), complex heart defect (P < 0.001), single ventricle physiology (P < 0.001) and right isomerism (P < 0.001) were significantly associated with cardiac reoperations. Single ventricle physiology was the only significant risk factor for cardiac reoperations in multivariate analyses (P < 0.001; Fig. 1D , Table 3 ).
In the subgroup of patients presenting with single ventricle physiology (n = 11), three children received a bidirectional Glenn anastomosis, two patients a repair of an insufficient atrioventricular valve, and one patient a shunt reoperation. One child was reoperated for pulmonary venous obstruction and shunt stenosis. This patient received three interventions for pulmonary venous obstruction, including stent implantation and stent dilatation. No intervention was performed in the remaining whole study population. In one patient, the Fontan pathway was completed by a total cavopulmonary connection at the second reoperation.
Reoperations for pulmonary venous obstruction. Most of the reoperations (n = 14) were required for pulmonary venous obstruction. Freedom from reoperation for pulmonary venous obstruction was 90.4 ± 2.5% at 20 years (Fig. 1E ). Among the potential risk factors listed in Table 1 , age at operation ≤30 days (P = 0.007) was the only significant risk factor for reoperation for pulmonary venous obstruction in the entire study population (Fig. 1F , Table 3 ).
Subgroup of 177 patients presenting with isolated TAPVC
Survival. Survival in patients presenting with isolated TAPVC was 87.2 ± 2.7% at 20 years ( Fig. 2A ). In the subgroup of patients with isolated TAPVC (n = 177), preoperative pulmonary venous obstruction (P = 0.030; Fig. 2B ) and deep hypothermic circulatory arrest (P = 0.017; Fig. 2C ) emerged as risk factors for mortality in univariate analyses (Table 4) .
Cardiac reoperations. Freedom from any cardiac reoperation, including reoperations for pulmonary venous obstruction, was 88.8 ± 3.0% at 20 years (Fig. 2D ). There was no significant influence of the potential risk factors listed in Table 1 on cardiac reoperations in patients presenting with isolated TAPVC (Table 4) .
Reoperations for pulmonary venous obstruction. Freedom from reoperation for pulmonary venous obstruction was 91.1 ± 2.6% at 20 years (Fig. 2E) . Among the potential risk factors listed in Table 1 , age at operation ≤30 days (P = 0.022) was the only significant risk factor for reoperation for pulmonary venous obstruction in patients presenting with isolated TAPVC (Fig. 2F , Table 4 ).
DISCUSSION
The present single-centre experience shows 94% survival without reoperations into the third decade following repair of TAPVC in 46% of the patients, irrespective of the type of anomalous connection. Hence, in the absence of any risk factors, repair of TAPVC is close to the ideal of a correction of the heart defect.
However, the present study reveals important risk factors that decrease the life expectancy of these patients to one of the lowest of all congenital heart defects. The most important risk factor is a functionally single ventricle physiology [7, 12] . In the present study, half of these patients died before the fifth year of Development of the pulmonary veins may be abnormal in these patients [13] ; therefore, pulmonary venous obstruction may develop and impair pulmonary blood flow. Subsequent elevation of pulmonary artery pressure can preclude these patients from completion of the Fontan circulation [14, 15] . However, bidirectional cavopulmonary shunt and additional pulmonary blood flow fails as a strategy for definitive palliation [16] . In the present study population, the Fontan circulation could be completed in only one of 11 patients.
Other previously published risk factors, such as pulmonary venous obstruction [6, 17] , connection type [6, 18] and low age at repair [6] , are difficult to assess and to interpret. There are three main limitations, namely the correlation of potential risk factors, long observation times and limited number of patients, as discussed in the following sections.
Correlation of potential risk factors
First, there is a strong correlation between the factors low age, pulmonary venous obstruction and connection type. Low age at repair is a surrogate of emergency operation for associated pulmonary venous obstruction, and pulmonary venous obstruction is predominantly present in the infracardic connection [19] . In the present study, age below 30 days and infracardiac connection were not significantly associated with mortality in univariate analyses. This is in contrast to previously published studies reporting infracardiac connection and mixed connection type as significant risk factors for mortality [17, 18] . We could confirm pulmonary venous obstruction as a significant risk factor for mortality in univariate analyses. Hence, there is evidence that pulmonary venous obstruction may be the most important determinant of mortality in the present cohort, irrespective of the type of connection and the age at repair. In the present Figure 1 : Overall survival after repair of total anomalous pulmonary venous connection (TAPVC; A), and overall survival stratified by single ventricle physiology (B). Freedom from cardiac reoperations after repair of TAPVC (C), and freedom from cardiac reoperations stratified by single ventricle physiology (D). Freedom from reoperations for pulmonary venous obstruction (PVO) after repair of TAPVC (E), and freedom from reoperations for PVO stratified by age <30 days at the time of repair (F). study, a functionally single ventricle was the only significant risk factor for mortality in multivariate analyses. A subanalyses, including only the patients with isolated TAPVC, revealed pulmonary venous obstruction as the only significant anatomical risk factor for mortality. Hence, there is further evidence that pulmonary venous obstruction may be the most important risk factor for mortality.
It is of note that in the present study, 54% of the patients presented with obstructed pulmonary venous return. Although Hancock Friesen and colleagues found an equally high number [7] , this is a higher percentage compared with other series, which found values ranging from to 25 to 48% [1, 4, 6] . The relatively high number of patients with obstructed pulmonary venous return in the present study may be attributed to the relatively high number of patients who presented with an infracardiac connection [19] . In the present study, 31% of the patients presented with an infracardiac connection, compared with 17-26% other series [1, 4, 6] .
Long observation times
A second reason for difficulty in assessment of risk factors is the long observation time of many studies. Repair in the 1970s has been identified as a risk factor for mortality compared with repair in the recent decade [2, 6, 20] . Changes in surgical strategy and perioperative medical management might have improved outcome. When including the year of surgery in our multivariate model, we could not identify an era effect towards lower mortality in the recent time period. However, in cases of isolated TAPVC, the use of deep hypothermic circulatory arrest emerged as a risk factor for mortality. This is in line with the findings of Mueller et al. and Bogers et al., who reported a beneficial outcome from the use of moderate hypothermia and low-flow cardiopulmonary bypass [3, 21] . However, Kirshbom et al. and Lincoln et al. could not confirm the use of deep hypothermic circulatory arrest as a risk factor for mortality despite a favourable era effect and a coincident change in perfusion strategy [17, 22] .
With the change of the bypass strategy, we also changed our surgical approach from the right side, with a large incision in both atria, to the left side, with an incision in the left atrium for connecting the pulmonary veins and a separate small incision in the right atrium for closing the atrial septal defect. However, as there has not been significantly better survival in the recent time period, we think that both surgical techniques are equally effective for correction of the anomalous venous return with regard to overall mortality. In contrast to Le Bret et al., who describe an optimal exposure by transection of the ascending aorta and the pulmonary trunk [23] , we did not experience significant limitations of exposure using the left-sided approach, even in patients presenting with a supracardiac type of connection.
Finally, we changed the suture material over time. In the early days, we used non-absorbable sutures, whereas in recent times we have used absorbable sutures. In contrast to Hawkins et al., who demonstrated improved results with the use of absorbable sutures regarding mortality and freedom from reoperation [8] , we did not experience improved results in recent times. In summary, evaluation of era effects on long-term mortality is limited owing to the influences of multiple factors and the differences in followup time. In our experience, survival can be improved by avoiding deep hypothermic circulatory arrest and by using moderate hypothermia and low-flow cardiopulmonary bypass.
Limited number of patients
A third reason for difficulty in the assessment of risk factors is the limited number of patients presenting with TAPVC. Large series include up to 377 patients [6] . However, multivariate analyses are limited owing to various missing values and the reduced event-rate-to-variable ratio [6] . The present multivariate analysis includes 190 patients with 31 events. As a result of the low number of missing values, it compares well in size with other previously published series [6] .
Reoperation is a major concern in patients following repair of TAPVC. The observed 90% freedom from reoperation in patients presenting with isolated TAPVC at 10 years compares well with previously published series, which have reported reoperation rates ranging between 9 and 13% [1, 6, 24] . A low age at correction emerged as the only risk factor for reoperation for pulmonary venous obstruction in the total cohort and in the subgroup of patients presenting with isolated TAPVC. This is interesting, because low age at correction was not associated with long-term mortality. We speculate that using a sutureless technique [25] at the time of the reoperation results in good survival rates following reoperation. Hence, in our experience, reoperations do not lead to a higher risk for mortality. In contrast to Hyde et al., we did not experience favourable results with balloon angioplasty for recurrent pulmonary venous obstruction [24] .
In conclusion, survival into the third decade without reoperations is excellent in patients with isolated TAPVC without pulmonary venous obstruction. On the contrary, the survival of patients with TAPVC and single ventricle physiology is among the poorest of all congenital heart defects. Reoperations for pulmonary venous obstruction are rare and are required predominantly in patients who were operated on as neonates. Survival may be improved by using a strategy of low-flow cardiopulmonary bypass.
Study limitations
The study design was a retrospective follow-up study covering a long period of patient inclusion. Changes in preoperative, operative and postoperative management may have affected the outcome parameters in a way not covered by our analysis. Owing to the partly historical character of this study, there are limitations in the definition of pulmonary venous obstruction. Owing to missing values, the level of obstruction was not eligible for statistical analysis.
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APPENDIX. CONFERENCE DISCUSSION
Dr F. Lacour-Gayet (New York, NY, USA): Your study, which reports the results of 193 patients after repair of total anomalous pulmonary venous connection with a follow-up of nearly 40 years, and 93% survival, is exceptional and provides interesting information. You confirm that single-ventricle physiology is a very high risk factor for mortality and reoperation for pulmonary venous obstruction, which is in line with the literature.
With regard to preoperative pulmonary vein obstruction, you report an incidence of 54%, which is quite high. There are two different types of preoperative pulmonary venous obstruction. One could be a hypoplasia of individual pulmonary veins or of the confluence, which is difficult to correct surgically. The other type of pulmonary venous obstruction is in relation to the collector and is seen essentially in patients with the infracardiac form.
So the first question to you is: How do you define exactly pulmonary vein obstruction and why did you have a 54% incidence? Dr Hörer: This is a partly historical collective of patients. This explains why we were not able to understand exactly all types of stenosis and their location. All of the patients who had an infracardiac connection presented with obstruction. These patients are in the same group with other patients who had stenosis, for example, in the vertical vein. So you're right, this is not a homogeneous definition of the risk factors. In retrospect, it's not possible to exactly determine the type of obstruction. Maybe it would be more consistent to exclude all patients with infracardiac connection from the analysis of recurrent pulmonary venous obstruction.
Dr Lacour-Gayet: My second question concerns the supracardiac form that is associated with the highest mortality. It's very surprising because this anatomy usually is favourable in most series. How do you explain that in your group it is the supracardiac and not the infracardiac or the miscellaneous forms that are associated with the highest risk of mortality?
Dr Hörer: I have no explanation for that. I deleted all patients with singleventricle physiology and this entity was no longer a risk factor. I do not think that our data are good enough to make the point that supracardiac connection is a risk factor.
Dr Lacour-Gayet: My final question is on circulatory arrest. Your study tends to prove that the outcome is superior without circulatory arrest. Actually, my personal experience, and that of others, is exactly the contrary. I moved from continuous perfusion to circulatory arrest to be able to use a 'no-touch technique', avoiding touching, dissection and clamping pulmonary veins to prevent pulmonary venous obstruction. My last question is to ask if you are convinced that avoiding circulatory arrest is better for prevention of pulmonary venous obstruction?
Dr Hörer: We stopped using deep circulatory arrest for almost all operations as part of an institutional policy. We operate on low-flow cardiopulmonary bypass. The result gave no evidence that low-flow cardiopulmonary bypass leads to inferior results. You're right, this may be attributed to the fact that the recent patients were operated on low flow, and changes in surgical technique and postoperative care may have an important impact on outcomes; however, the time of surgery was included in this analysis and it didn't turn out to be a risk factor. So, with our experience, now we are quite convinced that we can accomplish the anastomosis with low-flow cardiopulmonary bypass.
Dr E. Belli (Paris, France): You mentioned that in your early experience you used Prolene and then later on reabsorbable sutures. In your table, there was no significant difference in outcome, although the period advantage was in favour of the reabsorbable sutures because the other type was used in the 1970s and 1980s. You concluded in your last slide that reabsorbable sutures are better, without evidence, while some people are convinced that reabsorbable sutures are a source of scar formation and venous obstruction in this subset. Can you comment on this, please.
Dr Hörer: We found only a trend towards improved outcomes when using reabsorbable sutures (P value of 0.06). I mentioned that we examined a partly historic patient population. In recent times, we used solely reabsorbable sutures. Non-reabsorbable sutures were used in the early experience prior to 1980 or 1990. Despite having only weak evidence that reabsorbable sutures are better, we continue to use reabsorbable sutures for all anastomoses.
Dr B. Maruszewski (Warsaw, Poland): Jürgen, very short comment. I have to admit I was never aware of the risk of 50% pulmonary venous obstruction. Could you tell us what your inclusion criteria were for the obstruction group? How did you really categorize the patients as having obstructed veins?
Dr Hörer: As I already mentioned, this is a problem and it is a limitation of our study. Inclusion criteria or assignment to the obstruction group were taken from the notes from our cardiologists. We do not have angiographic data from every patient and, of course, we have no echocardiographic data from the patients operated on in our early experience.
